Enlight Renewable Energy Achieves Analyst Price Target
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Nov 25 2025
0mins
Source: NASDAQ.COM
Current Stock Performance: Enlight Renewable Energy Ltd (ENLT) shares have surpassed the average analyst 12-month target price of $37.00, trading at $37.71/share, prompting potential analyst reactions regarding valuation adjustments.
Analyst Target Range: Within the Zacks coverage universe, analyst targets for ENLT vary significantly, with one analyst setting a target as low as $27.00 and another as high as $45.00, indicating a standard deviation of $6.782.
Investor Considerations: The crossing of the average target price signals investors to evaluate whether the stock is on a trajectory towards higher targets or if it has become overvalued, suggesting a potential need to reassess their positions.
Analyst Ratings Overview: The article references a rating scale from 1 (Strong Buy) to 5 (Strong Sell) for ENLT, reflecting the collective insights of analysts covering the stock, as provided by Zacks Investment Research.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy ENLT?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on ENLT
Wall Street analysts forecast ENLT stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for ENLT is 41.57 USD with a low forecast of 35.00 USD and a high forecast of 47.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
6 Analyst Rating
3 Buy
1 Hold
2 Sell
Hold
Current: 57.890
Low
35.00
Averages
41.57
High
47.00
Current: 57.890
Low
35.00
Averages
41.57
High
47.00
About ENLT
Enlight Renewable Energy Ltd is an Israel-based company. Enlight Renewable Energy Ltd operates in the fields of wind energy and solar energy in Israel and in the international market. The Company has four geographical areas of activity such as, Renewable energy activity in Israel within this field, the company engages in the initiation, planning, development, financing, establishment and operation of photovoltaic projects that produce electricity from solar energy in Israel, Central-Eastern Europe that includes wind projects across Central Eastern Europe but also Balkan region , Western Europe where the Company works to develop and establish large wind projects in developed electricity markets in Western European countries, which are mostly based on the sale of electricity in Spain, Sweden and Ireland.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
S&P 500 Futures Decline in Pre-Market Session; ImmunityBio and Enlight Renewable Energy Take the Lead
- ImmunityBio Inc. Performance: ImmunityBio Inc. (IBRX) saw a significant increase of 20.3% in pre-market trading.
- Enlight Renewable Energy Ltd. Performance: Enlight Renewable Energy Ltd. (ENLT) experienced a rise of 7.7% in pre-market trading.
- Market Context: The U.S. stock markets are set to open in two hours, indicating potential volatility.
- Investor Sentiment: The pre-market gains for both companies suggest positive investor sentiment ahead of the market opening.
Continue Reading
Enlight Renewable Energy Downgraded to Underweight by JP Morgan, Stock Hits $51.50 High
- Price Volatility Warning: Enlight Renewable Energy's RSI at 71.9 indicates an overbought condition, and despite a 27% stock gain over the past month, JP Morgan downgraded its rating to Underweight while maintaining a $35 price target, signaling concerns about future performance.
- Settlement Impact: Hawaiian Electric Industries reached a $47.75 million shareholder settlement, and although its stock rose 11% in the past five days, an RSI of 71.1 suggests potential overbought risks that could undermine investor confidence.
- Earnings Growth Highlight: Ellomay Capital reported Q3 earnings of $0.93 per share, up from $0.52 year-over-year, and while its stock gained 27% in the past month, an RSI of 75.5 indicates excessive market optimism that may lead to a correction.
- Market Sentiment Analysis: Overall, three stocks in the utilities sector show overbought signals, prompting investors to carefully assess market trends to avoid potential price correction risks.
Continue Reading